Page last updated: 2024-10-20

pyrazole and Leukemia

pyrazole has been researched along with Leukemia in 2 studies

1H-pyrazole : The 1H-tautomer of pyrazole.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Santos Bubniak, LD1
Gaspar, PC1
de Moraes, ACR1
Bigolin, A1
de Souza, RK1
Buzzi, FC1
CorrĂȘa, R1
Filho, VC1
Bretanha, LC1
Micke, GA1
Nunes, RJ1
Santos-Silva, MC1
Insuasty, B1
Tigreros, A1
Orozco, F1
Quiroga, J1
AbonĂ­a, R1
Nogueras, M1
Sanchez, A1
Cobo, J1

Other Studies

2 other studies available for pyrazole and Leukemia

ArticleYear
Effects of 1,3,5-triphenyl-4,5-dihydro-1H-pyrazole derivatives on cell-cycle and apoptosis in human acute leukemia cell lines.
    Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Blood Coagulation; Cell Cycle; Cell Cycle Checkpoints; Cell Prolif

2017
Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents.
    Bioorganic & medicinal chemistry, 2010, Jul-15, Volume: 18, Issue:14

    Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chalcones; Drug Screening A

2010